Candidiasis by Candida glabrata, Candida nivariensis and Candida bracarensis in Galleria mellonella: Virulence and Therapeutic Responses to Echinocandins
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Candidiasis by Candida glabrata, Candida nivariensis and Candida bracarensis in Galleria mellonella: Virulence and Therapeutic Responses to Echinocandins
Authors
Keywords
-
Journal
Journal of Fungi
Volume 7, Issue 12, Pages 998
Publisher
MDPI AG
Online
2021-12-01
DOI
10.3390/jof7120998
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of CgTpo4 in Polyamine and Antimicrobial Peptide Resistance: Determining Virulence in Candida glabrata
- (2021) Mafalda Cavalheiro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular epidemiology, antifungal susceptibility and virulence factors of Candida glabrata complex strains in Kayseri/Turkey
- (2021) Özge Kaan et al. MICROBIAL PATHOGENESIS
- Impact of calmodulin inhibition by fluphenazine on susceptibility, biofilm formation and pathogenicity of caspofungin-resistant Candida glabrata
- (2020) Andrés Ceballos Garzon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait
- (2020) Zahraa F. Al-Baqsami et al. Scientific Reports
- Caenorhabditis elegans as a model system to assess Candida glabrata, Candida nivariensis and Candida bracarensis virulence and antifungal efficacy
- (2020) Ainara Hernando-Ortiz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland
- (2020) A. T. Coste et al. INFECTION
- Candidiasis and Mechanisms of Antifungal Resistance
- (2020) Somanon Bhattacharya et al. Antibiotics-Basel
- Candida nivariensis: Identification strategy in mycological laboratories
- (2020) N. Cartier et al. JOURNAL DE MYCOLOGIE MEDICALE
- First isolation of Candida nivariensis, an emerging fungal pathogen, in Kuwait
- (2020) Khaled Alobaid et al. MEDICAL PRINCIPLES AND PRACTICE
- Identification of Candida glabrata Transcriptional Regulators that Govern Stress Resistance and Virulence
- (2020) Elan E. Filler et al. INFECTION AND IMMUNITY
- Replicative Aging in Pathogenic Fungi
- (2020) Somanon Bhattacharya et al. Journal of Fungi
- Candida isolates causing candidemia show different degrees of virulence in Galleria mellonella
- (2019) Laura Judith Marcos-Zambrano et al. MEDICAL MYCOLOGY
- Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples – an Iranian multicentre study and a review of the literature
- (2019) Amir Arastehfar et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Lack of detection of Candida nivariensis and Candida bracarensis among 440 clinical Candida glabrata sensu lato isolates in Kuwait
- (2019) Mohammad Asadzadeh et al. PLoS One
- Enhanced Efflux Pump Activity in Old Candida glabrata Cells
- (2018) Somanon Bhattacharya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris
- (2018) Guillermo Quindós et al. INTERNATIONAL MICROBIOLOGY
- Echinocandin resistance among Candida isolates at an academic medical centre 2005–15: analysis of trends and outcomes
- (2018) Todd P McCarty et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Portrait of Matrix Gene Expression in Candida glabrata Biofilms with Stress Induced by Different Drugs
- (2018) Célia Rodrigues et al. Genes
- Spontaneous Mutational Frequency and FKS Mutation Rates Vary by Echinocandin Agent against Candida glabrata
- (2018) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Galleria mellonella as a host model to study Candida glabrata virulence and antifungal efficacy
- (2017) Lauren Ames et al. Virulence
- Generational distribution of a Candida glabrata population: Resilient old cells prevail, while younger cells dominate in the vulnerable host
- (2017) Tejas Bouklas et al. PLoS Pathogens
- A New Determinant of Candida glabrata Virulence: The Acetate Exporter CgDtr1
- (2017) Daniela Romão et al. Frontiers in Cellular and Infection Microbiology
- Identification and Antifungal Susceptibility Profiles of Candida nivariensis and Candida bracarensis in a Multi-Center Chinese Collection of Yeasts
- (2017) Xin Hou et al. Frontiers in Microbiology
- In VitroFungicidal Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis Evaluated by Time-Kill Studies
- (2015) Sandra Gil-Alonso et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dose escalation studies with caspofungin against Candida glabrata
- (2015) Marianna Domán et al. JOURNAL OF MEDICAL MICROBIOLOGY
- In VitroAntifungal Susceptibility of Candida glabrata to Caspofungin and the Presence ofFKSMutations Correlate with Treatment Response in an Immunocompromised Murine Model of Invasive Infection
- (2014) Fabiola Fernández-Silva et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of FKS Mutations in Candida glabrata: MIC Values, Echinocandin Resistance, and Multidrug Resistance
- (2014) Cau D. Pham et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia
- (2014) N. D. Beyda et al. CLINICAL INFECTIOUS DISEASES
- Antifungal Efficacy during Candida krusei Infection in Non-Conventional Models Correlates with the Yeast In Vitro Susceptibility Profile
- (2013) Liliana Scorzoni et al. PLoS One
- Candida parapsilosis,Candida orthopsilosis, andCandida metapsilosisvirulence in the non-conventional hostGalleria mellonella
- (2013) Sara Gago et al. Virulence
- Fks1 and Fks2 Are Functionally Redundant but Differentially Regulated in Candida glabrata: Implications for Echinocandin Resistance
- (2012) Santosh K. Katiyar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The non-mammalian hostGalleria mellonellacan be used to study the virulence of the fungal pathogenCandida tropicalisand the efficacy of antifungal drugs during infection by this pathogenic yeast
- (2012) Ana Cecilia Mesa-Arango et al. MEDICAL MYCOLOGY
- Primer caso de fungemia asociada a catéter por Candida nivariensis en la Península Ibérica
- (2012) Leyre M. López-Soria et al. REVISTA IBEROAMERICANA DE MICOLOGIA
- Comparative Effects of Micafungin, Caspofungin, and Anidulafungin against a Difficult-To-Treat Fungal Opportunistic Pathogen, Candida glabrata
- (2011) Elisabetta Spreghini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Echinocandins against Candida glabrata: Requirement for Dosage Escalation To Achieve Maximal Antifungal Activity in Neutropenic Hosts
- (2011) Susan J. Howard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Candida bracarensisBloodstream Infection in an Immunocompromised Patient
- (2010) Thomas A. Warren et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Identification of Candida nivariensis and Candida bracarensis in a Large Global Collection of Candida glabrata Isolates: Comparison to the Literature
- (2009) S. R. Lockhart et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Candida nivariensis, an Emerging Pathogenic Fungus with Multidrug Resistance to Antifungal Agents
- (2008) A. M. Borman et al. JOURNAL OF CLINICAL MICROBIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started